Similar articles

• [Idiopathic thrombocytopenic purpura: therapeutic aspects in the adult].

  Canevari A, Pagnucco G, Castelli G, Livraghi A, Santagostino A, Bernasconi C. Canevari A, et al. Haematologica. 1991 Jun;76 Suppl 3:124-30. Haematologica. 1991. PMID: 1752509 Review. Italian. No abstract available.
• Re: Recurrent immune thrombocytopenic purpura in children.

  Roganovic J, Letica-Crepulja M, Dordevic L. Roganovic J, et al. Pediatr Hematol Oncol. 2008 Apr-May;25(3):243-4. doi: 10.1080/08880010801938256. Pediatr Hematol Oncol. 2008. PMID: 18432509 No abstract available.
• Immune thrombocytopenic purpura.

  Cines DB, Blanchette VS. Cines DB, et al. N Engl J Med. 2002 Mar 28;346(13):995-1008. doi: 10.1056/NEJMra010501. N Engl J Med. 2002. PMID: 11919310 Review. No abstract available.
• Role of intravenous immunoglobulin G in autoimmune hematologic disorders.

  Blanchette VS, Kirby MA, Turner C. Blanchette VS, et al. Semin Hematol. 1992 Jul;29(3 Suppl 2):72-82. Semin Hematol. 1992. PMID: 1509297 Review.
• Autoimmune thrombocytopenic purpura complicating lymphoproliferative disorders.

  Lim SH, Ifthikharuddin JJ. Lim SH, et al. Leuk Lymphoma. 1994 Sep;15(1-2):61-4. doi: 10.3109/10428199409051678. Leuk Lymphoma. 1994. PMID: 7858503 Review.